Genmab | GEN - Market Capitalization


Genmab reported DKK106.96B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Almirall EUR 2.51B 251.72M May/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 189.89B 13.64B Mar/2026
argenx SE USD 39.98B 4.4B May/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Bayer EUR 37.69B 1.01B May/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Demant DKK 52.27B 6.26B May/2026
Exelixis USD 14.34B 3.44B May/2026
Fresenius Medical Care EUR 10.89B 429.56M May/2026
Genmab DKK 20.48B 1.02B Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
GN Store Nord DKK 14.08B 1.14B May/2026
GRIFOLS EUR 3.69B 1.9B May/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Insmed USD 15.56B 19.73B May/2026
Lakefront Biotherapeutics EUR 1.58B 147.61M May/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 52.48B 826.08M May/2026
Novartis USD 232.75B 75B May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
UCB EUR 46.41B 13.94B Dec/2025